Federal Appeals Court Sets Briefing Schedule in Medicare Hemp Program Challenge

The D.C. Circuit set briefing through December 16 in the appeal challenging CMSs optional, participant-funded hemp-product incentive after a district court dismissed the case for lack of standing. Oklahoma hemp suppliers and health-sector partners should monitor the appeal because it could affect one of the first federal care models to permit clinician-guided access to tested hemp products, although CMS does not reimburse the products.